Suchergebnisse - "Ishii, Tomonori"

PubPharm (226)

1

Development of anti-MDA5 autoantibody-positive dermatomyositis following the use of etanercept biosimilar in rheumatoid arthritis

enthalten in: Modern rheumatology case reports | 2024

von Okazaki, S. | Shirai, T. | Sato, H. | +2

2

Comment on : A case of vanishing bile duct syndrome during treatment of microscopic polyangiitis with avacopan

enthalten in: Rheumatology (Oxford, England) | 2024

von Shirota, S. | Shirai, T. | Mori, K. | +4

3

Establishing clinical remission criteria for giant cell arteritis : Results of a Delphi exercise carried out by an expert panel of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis

enthalten in: Modern rheumatology | 2024

von Sugihara, T. | Yoshifuji, H. | Uchida, H. | +13

4

Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis

enthalten in: Rheumatology (Oxford, England) | 2024

von Khanna, D. | Kramer, F. | Höfler, J. | +26

5

Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis

enthalten in: The New England journal of medicine | 2024

von Wechsler, M. | Nair, P. | Terrier, B. | +114

6

Impact of subcutaneous belimumab on disease activity, patient satisfaction, and metabolic profile in long-lasting systemic lupus erythematosus

enthalten in: Clinical rheumatology | 2024

von Yamato, M. | Shirai, T. | Ishii, Y. | +3

7

Impact of subcutaneous belimumab on disease activity, patient satisfaction, and metabolic profile in long-lasting systemic lupus erythematosus

enthalten in: Clinical rheumatology | 2024

von Yamato, M. | Shirai, T. | Ishii, Y. | +3

8

First reported case of pulmonary arteritis in patients with relapsing polychondritis

enthalten in: Rheumatology (Oxford, England) | 2024

von Yamato, M. | Shirai, T. | Sato, H. | +2

9

Real-world safety and effectiveness of mepolizumab for patients with eosinophilic granulomatosis with polyangiitis (EGPA) in Japan : 48-week interim analysis of the MARS study

enthalten in: Modern rheumatology | 2023

von Ishii, T. | Kunishige, H. | Kobayashi, T. | +6

10

Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc) : open-label, long-term extension of a phase 2b, randomised, placebo-controlled trial

enthalten in: The Lancet. Rheumatology | 2023

von Distler, O. | Allanore, Y. | Denton, C. | +24

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[23]